Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?
- PMID: 25405555
- DOI: 10.1097/SLA.0000000000001035
Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?
Comment in
-
Reply to Letter: "Response to Axillary Response Monitoring After Neoadjuvant Chemotherapy in Breast Cancer: Can We Avoid the Morbidity of Axillary Treatment?".Ann Surg. 2016 Feb;263(2):e29. doi: 10.1097/SLA.0000000000001036. Ann Surg. 2016. PMID: 25405561 No abstract available.
Comment on
-
Marking axillary lymph nodes with radioactive iodine seeds for axillary staging after neoadjuvant systemic treatment in breast cancer patients: the MARI procedure.Ann Surg. 2015 Feb;261(2):378-82. doi: 10.1097/SLA.0000000000000558. Ann Surg. 2015. PMID: 24743607 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical